Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Blood Cancer ; 63(8): 1488-90, 2016 08.
Article in English | MEDLINE | ID: mdl-27138381

ABSTRACT

Subcutaneous (SC) protein C (PC) was used in a child with purpura fulminans secondary to severe congenital PC deficiency. For maintenance, PC 80-120 IU/kg, given over 60-90 min SC Q48hr, has been successful as a home therapy for more than 3 years. The treatment was monitored by measuring trough PC chromogenic activity (target ≥15%) and D-dimer levels. No change in clinical course was appreciated after discontinuing enoxaparin (and leaving the patient on prophylactic PC replacement alone). A significant discrepancy between clotting-based and chromogenic-based PC activity is shown.


Subject(s)
Protein C Deficiency/drug therapy , Protein C Deficiency/pathology , Protein C/genetics , Protein C/therapeutic use , Anticoagulants/therapeutic use , Enoxaparin/therapeutic use , Female , Humans , Infant, Newborn , Liver Transplantation , Protein C/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL